메뉴 건너뛰기




Volumn 27, Issue 3, 2012, Pages 672-678

Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures

Author keywords

ATYPICAL SUBTROCHANTERIC FRACTURE; CORTICAL BONE; FOURIER TRANSFORM INFRARED IMAGING; HIP FRACTURE; MATERIAL PROPERTIES

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; COLLAGEN; IBANDRONIC ACID; RISEDRONIC ACID;

EID: 84857340290     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.560     Document Type: Article
Times cited : (170)

References (34)
  • 3
    • 0033552255 scopus 로고    scopus 로고
    • Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group
    • Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH 3rd, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD,. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999; 282 (14): 1344-52.
    • (1999) JAMA , vol.282 , Issue.14 , pp. 1344-1352
    • Harris, S.T.1    Watts, N.B.2    Genant, H.K.3    McKeever, C.D.4    Hangartner, T.5    Keller, M.6    Chesnut III, C.H.7    Brown, J.8    Eriksen, E.F.9    Hoseyni, M.S.10    Axelrod, D.W.11    Miller, P.D.12
  • 4
  • 5
    • 34147123172 scopus 로고    scopus 로고
    • Bisphosphonate efficacy and clinical trials for postmenopausal osteoporosis: Similarities and differences
    • Boonen S,. Bisphosphonate efficacy and clinical trials for postmenopausal osteoporosis: Similarities and differences. Bone. 2007; 40: S26-31.
    • (2007) Bone. , vol.40
    • Boonen, S.1
  • 6
    • 0036119735 scopus 로고    scopus 로고
    • Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs
    • Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, LaCroix AZ, Black DM,. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med. 2002; 112 (4): 281-9.
    • (2002) Am J Med. , vol.112 , Issue.4 , pp. 281-289
    • Cummings, S.R.1    Karpf, D.B.2    Harris, F.3    Genant, H.K.4    Ensrud, K.5    Lacroix, A.Z.6    Black, D.M.7
  • 7
    • 1642292806 scopus 로고    scopus 로고
    • Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy
    • Delmas PD, Seeman E,. Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone. 2004; 34 (4): 599-604.
    • (2004) Bone. , vol.34 , Issue.4 , pp. 599-604
    • Delmas, P.D.1    Seeman, E.2
  • 8
    • 63949084397 scopus 로고    scopus 로고
    • Spectroscopic markers of bone quality in alendronate-treated postmenopausal women
    • Boskey AL, Spevak L, Weinstein RS,. Spectroscopic markers of bone quality in alendronate-treated postmenopausal women. Osteoporos Int. 2009; 20 (5): 793-800.
    • (2009) Osteoporos Int. , vol.20 , Issue.5 , pp. 793-800
    • Boskey, A.L.1    Spevak, L.2    Weinstein, R.S.3
  • 9
    • 0034906270 scopus 로고    scopus 로고
    • Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women
    • Roschger P, Rinnerthaler S, Yates J, Rodan GA, Fratzl P, Klaushofer K,. Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. Bone. 2001; 29 (2): 185-91.
    • (2001) Bone. , vol.29 , Issue.2 , pp. 185-191
    • Roschger, P.1    Rinnerthaler, S.2    Yates, J.3    Rodan, G.A.4    Fratzl, P.5    Klaushofer, K.6
  • 10
    • 77649187517 scopus 로고    scopus 로고
    • Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity
    • Gourion-Arsiquaud S, Allen MR, Burr DB, Vashishth D, Tang SY, Boskey AL,. Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. Bone. 2010; 46 (3): 666-72.
    • (2010) Bone. , vol.46 , Issue.3 , pp. 666-672
    • Gourion-Arsiquaud, S.1    Allen, M.R.2    Burr, D.B.3    Vashishth, D.4    Tang, S.Y.5    Boskey, A.L.6
  • 14
    • 24144442926 scopus 로고    scopus 로고
    • Infrared analysis of bone in health and disease
    • Boskey A, Mendelsohn R,. Infrared analysis of bone in health and disease. J Biomed Opt. 2005; 10 (3): 031102.
    • (2005) J Biomed Opt. , vol.10 , Issue.3 , pp. 031102
    • Boskey, A.1    Mendelsohn, R.2
  • 16
    • 0026054727 scopus 로고
    • Novel infrared spectroscopic method for the determination of crystallinity of hydroxyapatite minerals
    • Pleshko N, Boskey A, Mendelsohn R,. Novel infrared spectroscopic method for the determination of crystallinity of hydroxyapatite minerals. Biophys J. 1991; 60 (4): 786-93.
    • (1991) Biophys J. , vol.60 , Issue.4 , pp. 786-793
    • Pleshko, N.1    Boskey, A.2    Mendelsohn, R.3
  • 17
    • 70349218082 scopus 로고    scopus 로고
    • Effects of 1 to 3 years' treatment with alendronate on mechanical properties of the femoral shaft in a canine model: Implications for subtrochanteric femoral fracture risk
    • Burr DB, Diab T, Koivunemi A, Koivunemi M, Allen MR,. Effects of 1 to 3 years' treatment with alendronate on mechanical properties of the femoral shaft in a canine model: implications for subtrochanteric femoral fracture risk. J Orthop Res. 2009; 27 (10): 1288-92.
    • (2009) J Orthop Res. , vol.27 , Issue.10 , pp. 1288-1292
    • Burr, D.B.1    Diab, T.2    Koivunemi, A.3    Koivunemi, M.4    Allen, M.R.5
  • 19
    • 70349276710 scopus 로고    scopus 로고
    • Trabecular packet-level lamellar density patterns differ by fracture status and bone formation rate in white females
    • Ciarelli TE, Tjhia C, Rao DS, Qiu S, Parfitt AM, Fyhrie DP,. Trabecular packet-level lamellar density patterns differ by fracture status and bone formation rate in white females. Bone. 2009; 45 (5): 903-8.
    • (2009) Bone. , vol.45 , Issue.5 , pp. 903-908
    • Ciarelli, T.E.1    Tjhia, C.2    Rao, D.S.3    Qiu, S.4    Parfitt, A.M.5    Fyhrie, D.P.6
  • 21
    • 34249909513 scopus 로고    scopus 로고
    • Nanoscale heterogeneity promotes energy dissipation in bone
    • Tai K, Dao M, Suresh S, Palazoglu A, Ortiz C,. Nanoscale heterogeneity promotes energy dissipation in bone. Nat Mater. 2007; 6 (6): 454-62.
    • (2007) Nat Mater. , vol.6 , Issue.6 , pp. 454-462
    • Tai, K.1    Dao, M.2    Suresh, S.3    Palazoglu, A.4    Ortiz, C.5
  • 22
    • 0000984831 scopus 로고
    • The mechanical consequences of variation in the mineral content of bone
    • Currey JD,. The mechanical consequences of variation in the mineral content of bone. J Biomech. 1969; 2 (1): 1-11.
    • (1969) J Biomech. , vol.2 , Issue.1 , pp. 1-11
    • Currey, J.D.1
  • 23
    • 1442324439 scopus 로고    scopus 로고
    • Tensile yield in compact bone is determined by strain, post-yield behaviour by mineral content
    • Currey JD,. Tensile yield in compact bone is determined by strain, post-yield behaviour by mineral content. J Biomech. 2007; 37 (4): 549-56.
    • (2007) J Biomech. , vol.37 , Issue.4 , pp. 549-556
    • Currey, J.D.1
  • 24
    • 79955722153 scopus 로고    scopus 로고
    • Bisphosphonate use and atypical fractures of the femoral shaft
    • Schilcher J, Michaelsson K, Aspenberg P,. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med. 2011; 364 (18): 1728-37.
    • (2011) N Engl J Med. , vol.364 , Issue.18 , pp. 1728-1737
    • Schilcher, J.1    Michaelsson, K.2    Aspenberg, P.3
  • 26
    • 0030832890 scopus 로고    scopus 로고
    • Variations in trabecular bone composition with anatomical site and age: Potential implications for bone quality assessment
    • Aerssens J, Boonen S, Joly J, Dequeker J,. Variations in trabecular bone composition with anatomical site and age: potential implications for bone quality assessment. J Endocrinol. 1997; 155 (3): 411-21.
    • (1997) J Endocrinol. , vol.155 , Issue.3 , pp. 411-421
    • Aerssens, J.1    Boonen, S.2    Joly, J.3    Dequeker, J.4
  • 27
    • 84857302144 scopus 로고    scopus 로고
    • Bone tissue composition varies across anatomic sites in the proximal femur and the iliac crest
    • DOI: 10.1002/jor.21574 [Epub ahead of print].
    • Donnelly E, Meredith DS, Nguyen JT, Boskey AL,. Bone tissue composition varies across anatomic sites in the proximal femur and the iliac crest. J Orthop Res. 2011; DOI: 10.1002/jor.21574 [Epub ahead of print].
    • (2011) J Orthop Res.
    • Donnelly, E.1    Meredith, D.S.2    Nguyen, J.T.3    Boskey, A.L.4
  • 28
    • 79958703451 scopus 로고    scopus 로고
    • Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: What we think we know and what we know that we don't know
    • Allen MR, Burr DB,. Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know. Bone. 2011; 49 (1): 56-65.
    • (2011) Bone. , vol.49 , Issue.1 , pp. 56-65
    • Allen, M.R.1    Burr, D.B.2
  • 29
    • 49549114063 scopus 로고    scopus 로고
    • Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs
    • Saito M, Mori S, Mashiba T, Komatsubara S, Marumo K,. Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs. Osteoporos Int. 2008; 19 (9): 1343-54.
    • (2008) Osteoporos Int. , vol.19 , Issue.9 , pp. 1343-1354
    • Saito, M.1    Mori, S.2    Mashiba, T.3    Komatsubara, S.4    Marumo, K.5
  • 30
    • 39049106609 scopus 로고    scopus 로고
    • Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra
    • Allen MR, Gineyts E, Leeming DJ, Burr DB, Delmas PD,. Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra. Osteoporos Int. 2008; 19 (3): 329-37.
    • (2008) Osteoporos Int. , vol.19 , Issue.3 , pp. 329-337
    • Allen, M.R.1    Gineyts, E.2    Leeming, D.J.3    Burr, D.B.4    Delmas, P.D.5
  • 31
    • 67349105623 scopus 로고    scopus 로고
    • Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate
    • Tang SY, Allen MR, Phipps R, Burr DB, Vashishth D,. Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate. Osteoporos Int. 2009; 20 (6): 887-94.
    • (2009) Osteoporos Int. , vol.20 , Issue.6 , pp. 887-894
    • Tang, S.Y.1    Allen, M.R.2    Phipps, R.3    Burr, D.B.4    Vashishth, D.5
  • 32
    • 33847728657 scopus 로고    scopus 로고
    • Effects of non-enzymatic glycation on cancellous bone fragility
    • Tang SY, Zeenath U, Vashishth D,. Effects of non-enzymatic glycation on cancellous bone fragility. Bone. 2007; 40 (4): 1144-51.
    • (2007) Bone. , vol.40 , Issue.4 , pp. 1144-1151
    • Tang, S.Y.1    Zeenath, U.2    Vashishth, D.3
  • 33
    • 33748175899 scopus 로고    scopus 로고
    • Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate
    • Allen MR, Iwata K, Phipps R, Burr DB,. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate. Bone. 2006; 39 (4): 872-9.
    • (2006) Bone. , vol.39 , Issue.4 , pp. 872-879
    • Allen, M.R.1    Iwata, K.2    Phipps, R.3    Burr, D.B.4
  • 34
    • 38449101476 scopus 로고    scopus 로고
    • Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment
    • Allen MR, Burr DB,. Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment. J Bone Miner Res. 2007; 22 (11): 1759-65.
    • (2007) J Bone Miner Res. , vol.22 , Issue.11 , pp. 1759-1765
    • Allen, M.R.1    Burr, D.B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.